SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dishman Pharmaceuticals strengthens on plan to raise up to Rs 200 crore through QIP

14 Aug 2014 Evaluate

Dishman Pharmaceuticals & Chemicals is currently trading at Rs 129.50, up by 1.25 points or 0.97% from its previous closing of Rs 128.25 on the BSE.

The scrip opened at Rs 129.00 and has touched a high and low of Rs 132.60 and Rs 128.15 respectively. So far 93848 shares were traded on the counter.

The BSE group 'B' stock of face value Rs 2 has touched a 52 week high of Rs 159.80 on 22-Jul-2014 and a 52 week low of Rs 39.65 on 28-Aug-2013.

Last one week high and low of the scrip stood at Rs 148.55 and Rs 126.00 respectively. The current market cap of the company is Rs 1034.94 crore.

The promoters holding in the company stood at 61.40% while Institutions and Non-Institutions held 14.75% and 23.85% respectively.

Dishman Pharmaceuticals & Chemicals has received an approval to raise up to Rs 200 crore by way of issue of shares to Qualified Institutional Investors (QIP), subject to approval of members. The board of directors at its meeting held on August 13, 2014 has approved for the same.

Dishman Pharmaceuticals is engaged in the manufacturing of active pharmaceutical ingredients (APIs) intermediates. The Company operates in two segments: contract research and contract manufacturing (CRAMS), and bulk drugs, intermediates, quats and specialty chemicals.

Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×